Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound
1 other identifier
observational
150
1 country
1
Brief Summary
Portal hypertension is a common and serious complication of liver cirrhosis, often leading to life-threatening conditions such as variceal bleeding, ascites, and hepatic encephalopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2025
CompletedFirst Submitted
Initial submission to the registry
June 26, 2025
CompletedFirst Posted
Study publicly available on registry
July 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedJuly 4, 2025
June 1, 2025
6 months
June 26, 2025
June 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Ultrasound Parameter Response
this questioner will take the data from the ultrasound values having liver chirosis
12 Months
Interventions
his study aims to determine the frequency of portal hypertension among patients with cirrhotic liver using ultrasound.A cross-sectional study will be conducted at Sheikh Zaid Medical College and Hospital, Rahim Yar Khan,
Eligibility Criteria
his study aims to determine the frequency of portal hypertension among patients with cirrhotic liver using ultrasound.A cross-sectional study will be conducted at Sheikh Zaid Medical College and Hospital, Rahim Yar Khan,
You may qualify if:
- Patients with a history of chronic liver disease (CLD) will be included.
- Both male and female patients will be included.
You may not qualify if:
- Non-cirrhotic liver patients
- Non-cooperative patients.Patients who do not provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheikh Zayed college/hospital
Rahim Yar Khan, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 26, 2025
First Posted
July 4, 2025
Study Start
March 17, 2025
Primary Completion
September 1, 2025
Study Completion
February 28, 2026
Last Updated
July 4, 2025
Record last verified: 2025-06